Department of Pathology (S.M.H.S.), University Medical Center, The
University of Arizona, Tucson, Arizona, and the
Department of Pathology
(A.A.N.), Beth Israel Deaconess Medical Center and Harvard Medical
School, Boston, Massachusetts
We investigated the potential of 16-desmethyl tirilazad mesylate, a
member of 21-aminosteroids, to ameliorate alcohol-induced liver injury.
Four groups (five rats/group) of male Wistar rats were studied. One
group of rats was fed fish oil and ethanol (FE) for 4 weeks, and a
second group received isocaloric amounts of dextrose instead of ethanol
(FD). The third (FE-LAZ) and fourth (FD-LAZ) groups received the
addition of 10 mg/kg/day of 16-desmethyl tirilazad mesylate (U74389)
daily via intragastric tube. Liver samples were analyzed
for histopathology, nonheme iron, lipid peroxidation and levels of mRNA
for tumor necrosis factor-
(TNF-
) and cyclooxygenase-2 (COX-2).
Concentrations of endotoxin and 8-isoprostane were measured in plasma.
Membrane ATPases were measured in isolated membrane red cells. FE rats
developed fatty liver, necrosis and inflammation. Treatment with the
21-aminosteroid resulted in prevention of necroinflammatory changes,
but the degree of fatty liver was unchanged. The absence of
necroinflammatory changes in the FE-LAZ group was accompanied by a
decrease in levels of nonheme iron, lipid peroxidation, TNF-
mRNA
and COX-2 mRNA. Ethanol administration decreased membrane
Ca++-ATPase and calmodulin-stimulated
Ca++-ATPase, and the decrease was reversed by
21-aminosteroid treatment. The data indicate that the improvement in
the degree of necrosis and inflammation in the rats treated with the
21-aminosteroid may be explained, at least in part, by reduced levels
of proinflammatory stimuli such as lipid peroxidation, TNF-
and
COX-2. Membrane stabilization may also, by reducing lipid peroxidation,
play an additional role in preventing liver injury.
 |
Introduction |
The
mechanism or mechanisms contributing to alcohol-induced liver damage
remain uncertain. There is increasing evidence that alcohol toxicity is
associated with increased oxidative stress and free radical-associated
injury (Cederbaum, 1989
; Nanji et al., 1994a
; Reinke
et al., 1987
). Several lines of investigation indicate that
the generation of oxygen metabolites such as superoxide (O2
), hydrogen peroxide and
hydroxyl radicals is believed to be important in the pathogenesis of
alcoholic liver injury (for reviews, see Nanji and Zakim, 1996
; and
Nordmann et al., 1992
). The notion that free
radical-mediated injury and enhanced lipid peroxidation are common
features of many different diseases has stimulated enthusiasm for the
potential use of antioxidants as therapeutic agents.
Recently, a new class of antioxidant agents, the 21-aminosteroids
(lazaroids, tirilazads), was developed (Hall et al., 1994
; Hall and Travis, 1988
). A growing body of evidence has confirmed the
ability of 21-aminosteroids to limit free radical-mediated organ injury
(Bagchi et al., 1995
; Liu et al., 1994
; Taylor
et al., 1996
). The exact mechanisms by which
21-aminosteroids protect against organ injury are unknown. One
hypothesis is that the beneficial effects of 21-aminosteroids are due
to their antioxidant- and free radical-scavenging properties (Braughler
et al., 1987
; Hall et al., 1994
). The other
proposed mechanism is stabilization of biological membranes (Wang
et al., 1996
).
The present study was designed to test the effectiveness of the
compound U74389, one of a novel series of 21-aminosteroids, in
ameliorating alcoholic liver injury. We used the intragastric feeding
rat model for alcoholic liver disease to determine the potential
protective effect of U74389 (16-desmethyl tirilazad mesylate). The
intragastric feeding model is ideally suited to this kind of study
because rats fed ethanol with unsaturated fatty acids develop fatty
liver, necrosis and inflammation (Nanji et al., 1994b
; Nanji
and French, 1989
). This model thus allows correlation between
improvement in biochemical markers such as lipid peroxidation and
histological evidence of liver injury (Nanji et al., 1995
).
It is also becoming increasingly apparent that in addition to promoting
direct toxicity, reactive oxygen intermediates initiate and/or amplify
inflammation through up-regulation of cytokines and proinflammatory
mediators (Suzuki et al., 1997
). We have recently shown that
up-regulation of TNF-
and COX-2 is associated with increased lipid
peroxidation in alcoholic liver injury (Nanji et al., 1997
).
Thus, it was important to determine the effect of the 21-aminosteroids
on these two inflammatory mediators. Finally, because 21-aminosteroids
demonstrate membrane-stabilizing effects, we evaluated its effect on
membrane ATPases. We have previously shown that ethanol administration
causes alterations in membrane ATPases that correlate with the presence
of pathological liver injury (Sadrzadeh et al., 1994a
).
 |
Materials and Methods |
Experimental design.
The experimental animals were male
Wistar rats weighing between 225 and 250 grams (Harlan-Sprague Dawley,
Indianapolis, IN). Four groups of rats (five rats per group) were
studied: FE, FD, FE-LAZ and FD-LAZ. The 21 aminosteroid U74389
(generously donated by Upjohn Co., Kalamazoo, MI) was administered
orally at a dose of 10 mg/kg/day at the same time each day. The rats
were maintained according to the National Institutes of Health
guidelines on the care and use of laboratory animals.
Animal model.
All animals were fed liquid diets containing
ethanol or isocaloric dextrose via continuous infusion
through permanently implanted gastric tubes as described previously
(French et al., 1986
; Tsukamoto et al., 1990
).
The rats were administered their total nutrient intake via
intragastric infusion. The percentage of calories from fat was 35% of
total calories. The fatty acid composition of the diets has been
described previously (Nanji et al., 1994a
). The diets were
prepared fresh daily and was supplemented with vitamins and minerals
(French et al., 1993
). The liquid diet (1 kcal/ml) was
infused at a rate of 180 ml/kg/day to achieve adequate weight gain. An
appropriate amount of ethanol was infused to maintain blood alcohol
levels between 150 and 300 mg/dl; this amount was initially 10 mg/kg/day and was increased to 15 mg/kg/day. All animals were killed 1 month after the initiation of feeding. When the animals were killed, a
sample of liver was obtained for histopathological analysis; the
remainder of the liver was rapidly excised, washed with ice-cold 1.15%
(w/v) KCl and cut into small pieces, which were transferred to plastic
vials and placed in liquid nitrogen. The vials were stored at
80°C.
Histological analysis.
A small sample of liver was obtained
through biopsy or at death and fixed in formalin. Hematoxylin and eosin
stain was used for light microscopy. The severity of liver pathology
was assessed as follows: steatosis (the percentage of liver cells
containing fat), 1+, <25% of cells containing fat; 2+, 26% to 50%;
3+, 51% to 75%; and 4+, >75%. Necrosis was evaluated as the number
of necrotic foci/mm2; inflammation was scored as
the number of inflammatory cells/mm2. At least
three different sections were examined per sample of liver.
Measurements of blood alcohol.
Blood was collected from the
tail vein, and ethanol concentration was measured using an alcohol
dehydrogenase kit from Sigma Chemical (St. Louis, MO).
Evaluation of lipid peroxidation.
Lipid peroxidation was
evaluated by measurements of TBARS in liver and 8-isoprostane
concentrations in plasma. Levels of TBARS were measured according to
the method of Ohkawa et al. (1979)
. 8-Isoprostanes were
measured with an immunoassay kit (Cayman Chemical, Ann Arbor, MI). The
blood sample was obtained from the aorta and immediately centrifuged,
and the plasma was stored at
70°C until analysis. We have
previously shown that 8-isoprostane levels in plasma correlate
extremely well with levels of conjugated dienes in liver (Nanji
et al., 1994a
).
RNA extraction from liver tissue and analysis using RT-PCR.
To examine the expression of TNF-
, COX-1 and -2 and
-actin in
liver tissue, total RNA was isolated according to the guanidinium isothiocynate method (Chomczynski and Sacchi, 1987
). RNA (0.5-1 µg)
was reverse-transcribed and amplified as described previously. The
sequences of primer pairs and predicted sizes of amplified fragments
have been given previously (Nanji et al., 1997
).
Amplification was performed in an automated thermal cycler at 94°C
for 60 sec, 50°C for 90 sec and 72°C for 2 min for 35 cycles,
followed by an additional 10-min extension period at 72°C. To account
for variations in the amount of reverse-transcribed RNA between
samples, all data were normalized to
-actin, which was measured by
the same technique. For identification of PCR products, aliquots from each PCR were electrophoresed on 1% agarose gel and visualized by
ethidium bromide staining. The gels were analyzed by laser scanning
densitometry using a Molecular Dynamics Densitometer and Image Quant
Software (Sunnyvale, CA). Each experiment included a negative control
(sample RNA that had not been subjected to RT).
Measurement of nonheme iron.
Nonheme iron was determined in
liver homogenate, with ferene S, as an indicator with the molar
absorptivity of 35,500 M
1·cm
1 at 594 nm
(Artiss et al., 1982
). The liver was homogenized in NaCl
solution (7 mM NaCl/100 mg of tissue) and centrifuged at 1000 × g for 10 min. The clear supernatant (150 µl) was mixed with deionized H2O (150 µl) and 150 µl of
thiourea/ascorbate solution (4.4% and 2.68% in deionized
H2O). Trichloroacetic acid (150 µl of 40%
solution) was added to the mixture, vortexed and centrifuged for 30 to
60 sec. The supernatant (500 µl) was then mixed with 125 µl of
fresh ferene S solution (35 mg of ferene S in 10 ml of 50% ammonium
acetate solution). The mixture was incubated at room temperature for 5 to 10 min, and the absorbance was read at 594 nm. Control experiments
were carried out to ensure that the measured nonheme iron was not from
nonspecific iron released from ferruginous compounds during the
procedures.
Measurement of membrane ATPases.
For ATPase determinations,
blood was collected from the aorta into heparinized tubes and
centrifuged immediately at 4°C to separate the red blood cells. Red
blood cell membranes were prepared according to the method of Farrance
and Vincenzi (1977)
, and ATPases were measured using a microtiter plate
assay (Sadrzadeh et al., 1993
).
Statistical analysis.
Results are presented as mean ± S.D. unless otherwise indicated. Analysis of variance and multiple
comparisons with the Student-Newman-Keuls method were used for
determination of statistical significance. Pearson's correlation
coefficient (r) was used for evaluation of associations.
 |
Results |
In each of the groups studied, the rats increased their weight at
a constant rate; there was no difference in weight gain among the
groups. There also was no difference in blood alcohol levels (mean ± S.E.M. mg/dl) in the two ethanol-fed groups (FE, 217 ± 36;
FE-LAZ, 238 ± 27).
Histopathology.
Feeding of the fish oil-ethanol diet for 1 month resulted in fatty liver, necrosis and inflammation (figs.
1 and 2).
There was no evidence of pathological changes in the dextrose-fed
groups. In the fish oil-ethanol-fed rats who were treated with the
U74389 (FE-LAZ), there was complete absence of both necrosis and
inflammation (figs. 1 and 3). However,
the degree of fatty liver was not affected by drug treatment.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Severity of pathological changes in the different
experimental groups. Compared with dextrose-fed control animals, FE
animals had significantly greater degrees of fatty liver (4.0 ± 0.0) (P < .01), necrosis (1.0 ± 0.3 vs.
0.03 ± 0.02 cells/mm2, P < .01) and
inflammation (27.7 ± 11.7 vs. 0.5 ± 0.3 cells/mm2, P < .01). Treatment with the
21-aminosteroid U74389 significantly attenuated the degree of necrosis
(0.0) and inflammation (0.2 ± 0.1) (P < .01). The degree of
fatty liver was not affected. *P < .01 vs. FD
and FD+LAZ; **P < .01 vs. all other groups.
|
|

View larger version (155K):
[in this window]
[in a new window]
|
Fig. 2.
Liver from a rat fed fish oil and ethanol for 4 weeks showing the presence of fatty liver, necrosis and inflammation
(hematoxylin and eosin, ×155).
|
|

View larger version (165K):
[in this window]
[in a new window]
|
Fig. 3.
Liver from a rat fed fish oil, ethanol and U74389
for 4 weeks. Only fatty liver is present (hematoxylin and eosin,
×155).
|
|
Nonheme iron and lipid peroxidation.
As previously reported,
nonheme iron levels were significantly increased in ethanol-fed rats
compared with control animals (fig. 4)
(P < .01). Of note was the increase in nonheme iron levels by
U74389 treatment in the dextrose-fed groups. Treatment with U74389 in
the ethanol-fed group led to a significant decrease in nonheme iron
levels (P < .01). The level of nonheme iron in the FE-LAZ group
decreased to that seen in the FD-LAZ group but not to that seen in the
FD group. Our hypothesis that treatment of ethanol-fed rats with U74389
should result in decreased levels of lipid peroxidation is supported by
measurements of TBARS and 8-isoprostane. The levels of both TBARS and
8-isoprostane were significant lower in ethanol-fed rats after
treatment with U74389 (fig. 4). U74389 treatment had no effect on lipid
peroxidation in dextrose-treated rats.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Alterations in nonheme iron and lipid peroxidation
in the different experimental groups. Ethanol administration
significantly increased nonheme iron levels (28.8 ± 3.4 µg in
FE vs. 12.6 ± 0.3 µg in FD). Treatment with
U74389 significantly decrease iron levels in ethanol-fed rats
(21.1 ± 1.3, P < .01). Similarly, ethanol administration
increased levels of TBARS in liver (P < .01) and 8-isoprostane in
plasma (P < .01), both of which were significantly decreased in
the 21-aminosteroid-treated groups (P < .01). *P < .01 vs. FD; ** P < .01 vs. other
groups.
|
|
Membrane ATPases.
The results of the present study confirm our
previous observations (Sadrzadeh et al., 1994b
) that ethanol
administration leads to a decrease in Ca++ pump
ATPase activity (P < .01) (fig. 5).
The reversal of changes in the activities of Ca++
pump ATPase and CaM in the FE+LAZ group supports the hypothesis that
treatment with U74389 leads to membrane stabilization. In fact, both
Ca++-ATPase and CaM activities were normalized to
levels seen in dextrose-fed control animals (fig. 5). A role for lipid
peroxidation in alternating Ca++ pump ATPase
activity in ethanol-fed rats is suggested by the inverse correlation
between 8-isoprostane levels in plasma and Ca++-ATPase activity (fig.
6, r =
.80, P < .01) and CaM (r =
.80, P < .01)

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 5.
Alteration in Ca++ pump ATPase and CaM
in the different experimental groups. Ethanol significantly decreased
Ca++ pump ATPase and CaM compared with dextrose-fed
controls (Ca++-ATPase: 11.0 ± 0.8 in FE
vs. 25.2 ± 1.2 in FD; CaM: 43.0 ± 5.5 in FE
vs. 81.5 ± 9.4 in FD) (P < .01). The
decreased in the activities of Ca++-ATPase and CaM was
reversed to levels seen in dextrose-fed rats in the U74389-treated
groups. *P < .01 vs. other groups.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
Significant inverse correlations between
8-isoprostane levels in plasma and red cell membrane
Ca++-ATPase (r = .80, P < .01)
and CaM (r = .80, P < .01).
|
|
Effect of tirilazad mesylate treatment on TNF-
and COX-2
mRNA.
The observation that TNF-
and COX-2 mRNAs are detectable
in rats fed fish oil and ethanol was confirmed in the present study (fig. 7). In support of the hypothesis
that decreased lipid peroxidation would lead to down-regulation of
TNF-
and COX-2, our results show that COX-2 and TNF-
mRNAs were
not detected in the FE+LAZ group. The levels of COX-1 mRNA were similar
in all groups.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 7.
RT-PCR analysis of mRNAs for TNF- , COX-2, COX-1
and -actin in liver samples obtained from the different groups.
COX-2 and TNF- mRNAs were detected only in fish oil-ethanol-fed
rats. None of the rats in the other groups had detectable TNF- or
COX-2 mRNA. COX-1 mRNA was present in all groups at the same levels. -actin was used as a control.
|
|
 |
Discussion |
The objective of this study was to determine the effect of
tirilazad mesylate (U74389) on alcohol-induced liver injury. The effect
of the drug was tested in the intragastric feeding rat model for
alcoholic liver disease. We (Nanji et al., 1994a
) and others
(Morimoto et al., 1994
) have previously shown that feeding ethanol with fish oil results in the development of fatty liver, necrosis and inflammation. The model also makes it possible to make
correlations between biochemical changes and the severity of
pathological liver injury. The major observation in the present study
was that the 21-aminosteroid U74389 was able to completely prevent
necrosis and inflammation in rats fed fish oil and ethanol. The absence
of necroinflammatory changes was accompanied by down-regulation of the
proinflammatory mediators TNF-
and COX-2 and decreased levels of
lipid peroxidation. There is a growing body of evidence that implicates
TNF-
in alcoholic liver disease and hepatocellular injury (McClain
et al., 1993
; McClain and Cohen, 1989
; Nanji et al., 1994c
). It is also recognized that COX-2, via
production of vasoactive and proinflammatory compounds, is important in
tissue and hepatocellular injury (Dinchuk et al., 1995
;
Nanji et al., 1997
). Of note is that the levels of plasma
endotoxin, another stimulus for TNF-
and COX-2 up-regulation (Hempel
et al., 1994
; Hla et al., 1993
), were not altered
by U74389 treatment. This observation is important because it suggests
that endotoxin and lipid peroxidation are two independent mediators of
the necroinflammatory process in alcoholic liver injury. In recent
years, it has become increasingly apparent that in addition to
promoting direct toxicity, reactive oxygen intermediates may initiate
and/or amplify inflammation through up-regulation of several different
genes involved in the inflammatory response (Chaudri and Clark, 1989
;
Gossart et al., 1996
; Schreck and Baeuerle, 1991
). One of
the consequences of enhanced lipid peroxidation is the up-regulation of
TNF-
and COX-2 (Feng et al., 1995
). Our previous studies
have shown that TNF-
and COX-2 in Kupffer cells are up-regulated in
ethanol-fed rats showing evidence of necroinflammatory changes (Nanji
et al., 1997
). Activation of certain transcription factors
such as NF-
B are important in regulating expression of
proinflammatory cytokines (Baeuerle and Henkel, 1994
). It has been
recently shown that activation of NF-
B and up-regulation of
proinflammatory cytokines occur in ethanol-fed rats exhibiting
necroinflammatory changes in the liver (Pham et al., 1996
).
Antioxidants such as 21-aminosteroids can protect not only against
direct oxygen radical-mediated toxicity but also through their ability
to inhibit the activation of NF-
B and subsequent production of
proinflammatory mediators (Suzuki et al., 1997
). Such a
protective effect is suggested by the present study in the
down-regulation of TNF-
and COX-2 in ethanol-fed rats treated with
one of the 21-aminosteroids, tirilazad mesylate.
Evidence suggests that 21-aminosteroids are able to limit free
radical-mediated organ injury (Braughler and Pregenzer, 1989
). Although
the exact mechanism or mechanisms by which these compounds inhibit cell
injury have yet to be elucidated, one proposed mechanism is inhibition
of lipid peroxidation by scavenging free radicals and thus blocking the
lipid chain reaction, a mechanism analogous to that of
-tocopherol
(Hall et al., 1994
). The inhibition of lipid peroxidation in
the present study was reflected in the decrease in levels of TBARS and
8-isoprostane in 16-desmethyl tirilazad mesylate-treated group. The
formation of 8-isoprostane occurs in vivo via a non-COX free
radical-catalyzed mechanism of unsaturated fatty acids (Morrow et
al., 1992
). The alterations in lipid peroxide levels in
ethanol-fed and drug-treated rats closely mirrored alterations in
levels of nonheme iron in the liver. The contribution of nonheme iron
to enhanced oxidative stress in ethanol-fed rats has been suggested by
several investigators (Bacon and Britton, 1990
; Bonkovsky et
al., 1996
). Iron supplementation in a high-fat/ethanol diet caused
a marked increase in 4-hydroxynonenal and malondialdehyde levels in the
liver (Tsukamoto et al., 1995
). Furthermore, we have shown
that a reduction in nonheme iron levels by the use of oral iron
chelators results in decreased lipid peroxidation and improvement in
liver pathology (Sadrzadeh et al., 1994). Whether the
decrease in nonheme iron levels in ethanol-fed rats treated with U74389
was a direct effect of the drug or a result of inhibition of lipid
peroxidation cannot be deduced from the present study. There is
evidence that superoxide, generated as a result of ethanol metabolism,
can mobilize free iron from ferritin (Shaw et al., 1988
;
Shaw and Jayatilleke, 1992
). Thus, a reduction in free radical levels
by free radical scavengers would be anticipated to result in lower
nonheme iron levels.
The possible protection against liver injury by U74389 through a
membrane-stabilizing effect is supported by measurements of
Ca++ pump ATPase and CaM; the normalization of
both Ca++ pump ATPase and CaM by U74389 is
consistent with a membrane-stabilizing effect. We have previously shown
that chronic ethanol administration leads to a decrease in red cell
membrane Ca++ pump ATPase activity (Sadrzadeh
et al., 1994), and there is evidence that nonheme iron,
which promotes lipid peroxidation, can lead to inhibition of
Ca++ pump ATPase (Wei and Sadrzadeh, 1994
).
Although we measured red cell membrane ATPases rather than hepatocyte
membrane ATPases, previous studies in ethanol-treated rats have shown
similar changes in hepatocytes and red cell membranes in response to
ethanol (Israel et al., 1970
). Wang et al. (1996)
have shown a membrane-stabilizing effect of 21-aminosteroids and
protection against liver injury in rats subjected to hepatic ischemia
and reperfusion. These investigators also showed a decreased
inflammatory response in the livers of rats treated with a
21-aminosteroid. Thus, the decrease in the necroinflammatory reaction
in the animals treated with U74389 could in part be due to a
membrane-stabilizing effect. In addition, membrane stabilization will
affect the propagation phase of lipid peroxidation and therefore
indirectly reduce hepatic lipid peroxidation. Reduction in free radical
production by inflammatory cells could also result from this
membrane-stabilizing effect.
In conclusion, our results show that the improvement in
necroinflammatory changes in fish oil-ethanol-fed rats treated with a
tirilazad mesylate were accompanied by a reduction in the degree of
lipid peroxidation and in expression of TNF-
and COX-2. The reduction in TNF-
and COX-2 expression most likely contributed to
the reduction in the severity of pathological change. Although the
decrease in lipid peroxidation is believed to be the mechanism for the
improvement in liver pathology, a membrane-stabilizing effect of
tirilazad mesylate is also likely to be important.
16-Desmethyl tirilazad mesylate was generously supplied by the
Upjohn Company (Kalamazoo, MI).
Accepted for publication August 20, 1997.
Received for publication March 19, 1997.